FDA Clears 50mm Magnet for GT Metabolic’s MagDI System

GT Metabolic Solutions, a company specializing in magnetic surgery, has earned U.S. Food and Drug Administration (FDA) clearance for a larger, 50 mm MagDI magnet to complement the system’s current 40 mm magnet.

The expansion allows surgeons to accommodate a wider range of patients in magnet-assisted surgery for duodenal-ilial anastomosis. The MagDI system is currently the only FDA-cleared, commercially available product for magnetic compression anastomosis.

The MagDI system is a self-aligning, incisionless, sutureless, and staple-free technology designed to facilitate anastomosis while leaving behind no foreign material. The larger magnet will be used in the same procedure as the 40 mm magnet.

“This expansion reinforces our commitment to pushing the boundaries of minimally invasive, magnetic surgery and providing surgeons with more advanced tools to improve patient outcomes,” said Thierry Thaure, co-founder and CEO of GT Metabolic Solutions.

“We are eager to bring this transformative approach to even more surgeons and patients,” added Michel Gagner, MD, chief medical officer and co-founder of GT Metabolic Solutions, who created the system. “The clinical success we’ve seen so far reinforces the role of magnetic compression for anastomosis in bariatric surgery today and bringing the option of a larger 50mm magnet allows us to broaden the impact of the MagDI System.”